1. Home
  2. Labeler Index
  3. Novavax, Inc.
  4. 80631-207
  5. NDC Package Code: 80631-207-10 Nuvaxovid Covid-19 Vaccine, Adjuvanted

NDC Package 80631-207-10 Nuvaxovid Covid-19 Vaccine, Adjuvanted

Nvx-cov2705 Injection, Suspension Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
80631-207-10
Package Description:
10 SYRINGE, GLASS in 1 CARTON / .5 mL in 1 SYRINGE, GLASS (80631-207-01)
Product Code:
80631-207
Proprietary Name:
Nuvaxovid Covid-19 Vaccine, Adjuvanted
Non-Proprietary Name:
Nvx-cov2705
Substance Name:
Nvx-cov2705
11-Digit NDC Billing Format:
80631020710
Product Type:
Vaccine
Labeler Name:
Novavax, Inc.
Dosage Form:
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Administration Route(s):
Intramuscular - Administration within a muscle.
Active Ingredient(s):
NVX-COV2705 5 ug/.5mL
Sample Package:
No
FDA Application Number:
BLA125817
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
08-27-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 80631-207-10?

The NDC Packaged Code 80631-207-10 is assigned to a package of 10 syringe, glass in 1 carton / .5 ml in 1 syringe, glass (80631-207-01) of Nuvaxovid Covid-19 Vaccine, Adjuvanted, a vaccine label labeled by Novavax, Inc.. The product's dosage form is injection, suspension and is administered via intramuscular form.

Is NDC 80631-207 included in the NDC Directory?

Yes, Nuvaxovid Covid-19 Vaccine, Adjuvanted with product code 80631-207 is active and included in the NDC Directory. The product was first marketed by Novavax, Inc. on August 27, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 80631-207-10?

The 11-digit format is 80631020710. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-280631-207-105-4-280631-0207-10